ARCHIVES

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

This article is from The Cancer Letter archive.

Vol. 40 No. 16 | April 18, 2014

Download PDF Visit The Full Archive

Related Articles

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006